The Client

Novartis reimagines medicine to improve and extend people’s lives using innovative science and technology to address some of society’s most challenging healthcare issues. They discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Faran SA is a Greek pharmaceutical company that aims to offer renowned High Quality therapeutic products, with High Therapeutic Value, Modern Pharmaceutical Technology and Documented Safety.


The Project

Lapatinib is a targeted cancer drug (biological therapy) and is also known by its brand name, Tyverb. In North America it is called Tykerb.

It is a treatment for advanced breast cancer that have large amounts of a protein called human epidermal growth factor receptor 2 (HER2). Researchers are also looking at using it to treat other types of cancer.